NCT06172374View on ClinicalTrials.gov

A Study Providing Genetic Testing to Find Those Who May Have Primary Ciliary Dyskinesia for Potential Clinical Trials

Active, not recruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

August 31, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

December 31, 2025

Conditions
Primary Ciliary Dyskinesia
Interventions
GENETIC

Sano Genetics Testing Kit

Genetic testing spit collection tubes for DNA testing

Trial Locations (1)

94025

ReCode Therapeutics, Inc., Menlo Park

Sponsors

Collaborators (1)

Sano Genetics
All Listed Sponsors
collaborator

Sano Genetics

INDUSTRY

collaborator

Reverba

UNKNOWN

lead

ReCode Therapeutics

INDUSTRY

NCT06172374 - A Study Providing Genetic Testing to Find Those Who May Have Primary Ciliary Dyskinesia for Potential Clinical Trials | Biotech Hunter | Biotech Hunter